Pharmaceutical industry funding of health consumer groups in Australia (January 2013 to December 2016)

This project stems from the Evidence, Policy and Influence Collaborative, led by Prof Lisa Bero, which seeks to translate rigorous and unbiased evidence into clinical practice and health policy.
The dataset contains 130 company transparency reports covering the period from January 2013 to December 2016.The PDF reports were downloaded from the website of Medicines Australia and converted in Excel files. These reportscover information on the sponsoring company, the recipient health consumer organisations, the nature of thesupport, and the monetary value of the sponsorship (or the non-monetary value in case of non-financial support).